4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-23-041338
Chief Development Officer sold 1,004 shares at $25.65 ($25,749)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Longpre Lara Chief Development Officer | 2023-07-03 | Sale | −1,004 | $25.65 | $25,749 | 105,839 | D |
| Open-market sales · 1,004 sh · avg $25.65 · $25,749 | |||||||
Loading xslF345X04/doc4.xml…